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Expression patterns in the globin gene cluster are subject to developmental regulation in vivo. While the c
A and c
G genes are
expressed in fetal liver, both are silenced in adult erythrocytes. In order to decipher the role of DNA methylation in this
process, we generated a YAC transgenic mouse system that allowed us to control c
A methylation during development. DNA
methylation causes a 20-fold repression of c
A both in non-erythroid and adult erythroid cells. In erythroid cells this
modification works as a dominant mechanism to repress c gene expression, probably through changes in histone acetylation
that prevent the binding of erythroid transcription factors to the promoter. These studies demonstrate that DNA methylation
serves as an elegant in vivo fine-tuning device for selecting appropriate genes in the globin locus. In addition, our findings
provide a mechanism for understanding the high levels of c-globin transcription seen in patients with Hereditary Persistence of
Fetal Hemoglobin, and help explain why 5azaC and butyrate compounds stimulate c-globin expression in patients with b-
hemoglobinopathies.
Citation: Goren A, Simchen G, Fibach E, Szabo PE, Tanimoto K, et al. (2006) Fine Tuning of Globin Gene Expression by DNA Methylation. PLoS
ONE 1(1): e46. doi:10.1371/journal.pone.0000046
INTRODUCTION
Genome wide DNA methylation is set up during early de-
velopment and then maintained in a semi-conservative manner
through every cell division [1]. The presence of methyl groups
apparently serves as a molecular signal that can direct the
packaging of DNA into a closed inaccessible chromatin confor-
mation [2] and bring about the local deacetylation of histones H3
and H4 [3]. Because of these observations, it has been postulated
that methylation may serve as a global mechanism for repression
of basal transcription [4]. In keeping with this organization, many
tissue specific genes are found methylated in almost all cell types of
the organism, but undergo developmentally regulated demethyla-
tion in their cell type of expression [5]. Little is known about the
role of DNA methylation in this differentiation process.
A good system for studying gene specific methylation is the
human b-globin locus on chromosome 11 which is composed of
five different b-type genes that are expressed in a regulated
manner during development [6]. In non-erythroid cells, the entire
locus replicates late in S phase [7–9] and is packaged into a closed
DNaseI-insensitive chromatin conformation, where all of the
individual genes are methylated. In contrast, during erythroid cell
specific differentiation, the full locus undergoes an ‘‘opening’’
process, becoming early replicating and generally DNaseI sensitive
[10], but only specific genes undergo demethylation and actually
become transcriptionally active. Thus, for example, c-globin genes
are preferentially active in the fetal liver, while mainly the b gene is
active in adult erythroid cells where both c
A and c
G remain
methylated [11] and silenced in a process that appears to be
mediated by MBD2 [12].
Using a genetic approach in transgenic mice we demonstrate
that DNA methylation plays a local role in preventing the
activation of c globin in adult erythroid cells, and this effect is
mediated by histone deacetylation and the prevention of factor
binding. These findings provide a strong experimental basis
for approaches aimed at inducing c expression in cases of
b-Thalassemia through treatments that bring about DNA
demethylation or histone acetylation. Our results also suggest that
demethylation may be an obligatory step in the molecular
mechanisms that bring about the abnormal expression of c globin
seen in Hereditary Persistence of Fetal Hemoglobin.
RESULTS
Experimental strategy
In order to determine the precise role of DNA methylation in the
repression of c-globin gene expression, we devised a biological
approach for controlling local methylation. For this purpose we
used a (Yeast Artificial Chromosome) YAC transgene carrying the
entire human b-globin locus that has been shown to be properly
regulated in the mouse [13,14]. During early development, at the
time of implantation, CpG island regions are recognized and
protected from the process of de novo methylation [15]. This is
accomplished through the involvement of cis acting sequences
[16,17], and one such element (IE—Island Element) identified in
the Aprt locus, has been shown to work dominantly to prevent
methylation of transgenes in vivo [3]. Preliminary experiments
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c-globin promoter could generate a relatively large (1 kb)
unmethylated region that was then maintained in all somatic cells
of the mouse (see Materials and Methods). On the basis of this
observation we engineered a duplicated IE sequence flanked with
LoxP sites 40 bp upstream to the c
A -globin gene transcription
start site in a 150 kb YAC which carries the entire human b-globin
locus [18], and this construct was used to generate transgenic mice
(Figure 1A). Four founder animals with intact YACs were
obtained, and Southern blot analysis showed that 3 of them (47,
64, 113) were completely unmethylated at one selective restriction
site in the c
A gene promoter, indicating that this strategy was
successful (Figure 1B). In one transgenic animal (66), the promoter
remained partially methylated.
In order to manipulate DNA methylation and thereby test its
effect on c
A transcription, transgenic mice were crossed with two
types of cre-expressing animals. The first line of cre mice (Cre)
contain an expression vector which is constitutively active in all
cell types from very early stages in development [19]. In F1
animals generated from this cross, the IE would be removed prior
to implantation and, as a result, the c
A gene becomes methylated
(see Figure 1). The Mx-Cre mouse, in contrast, contains an
interferon-inducible cre gene [20]. In F1 animals from this cross,
the c
A gene should be protected from de novo methylation at the
time of implantation. In the adult, the IE can be removed by
treatment with interferon, but the gene should still remain
unmodified. Thus, using this strategy, it should be possible to
generate matched transgenic mice with a fixed integration site
whose only difference is the DNA methylation state at the c
A
promoter throughout the organism [21].
Effect of DNA methylation on gene expression
Using the globin YAC transgene, it was now possible to determine
the effect of DNA methylation on transcription of the c
A gene in
both non-erythroid and erythroid cells. As non-erythroid cells, we
Figure 1. Programmed methylation of the human c
A-globin promoter
A. Two IEs (yellow) bounded by loxP elements (stippled black) were
inserted into the c
A promoter region of a YAC containing the human b-
globin locus [18], and this was used to generate transgenic mice that
were then crossed with two different cre-expressing lines. In the first
line (Cre) [19], cre is expressed (red) prior to implantation. In mice
carrying this construct the IE is deleted before the wave of de novo
methylation, and surrounding CpG sites thus become methylated (red
circles). The second cre-expressing line carries interferon-inducible cre
[20]. In these mice (Mx-cre), the IE remains present during implantation
and protects adjacent regions from methylation. By treating adult
animals with polyI-polyC, cre activity could be induced (red) and the IE
removed, generating an unmethylated version of the transgene.
B. Tail DNA from four transgenic founders (lines 47, 64, 66 and 113) was
cut with AvrII with or without the methylation sensitive restriction
enzyme BsrFI, and subjected to Southern blotting using a radioactive
probe (green arrow). Line 47 was crossed with cre mice and offspring
analyzed in the same way.
C. The region upstream of the c
A and c
G coding sequences (blue
triangles) was analyzed for CpG methylation using the bisulfite
technique. To this end we generated MEFs from line 64 (IE present at
time of implantation) and infected them with an adenovirus that
expresses Cre activity. Alternatively, we derived MEFs from line 64 mice
crossed with Cre (IE removed prior to implantation). Five CpG residues
were analyzed for methylation in the c
G promoter. The normal c
A
promoter also carries 5 CpGs, but one is replaced by the inserted loxP
element. Following bisulfite treatment, PCR products were cloned and
subjected to sequencing. Each row represents a single molecule. Black
circles indicate a methylated CpG, whereas open circles indicate a lack
of methylation. The numbers in the margin indicate how many clones
were fully methylated.
doi:10.1371/journal.pone.0000046.g001
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Mx-Cre transgenic (line 64) crosses. The bisulfite sequencing
technique was used to measure the methylation state at the c
A and
c
G promoters. In cells in which the IE was removed pre-
implantation (Cre), the c
A gene was found to be completely
methylated at 4 upstream CpG sites. In contrast, cells that retained
the IE during implantation (Mx-Cre) were highly unmethylated in
this same region (Figure 1C). The c
G promoter provided an
important control that remained methylated in all MEFs from
transgenic mice.
Semi-quantitative RT-PCR was used to determine the level of
expression of the c as well as b-globin genes. We took advantage of
a unique restriction enzyme site within the c
A gene to distinguish
between c
A and c
G transcripts. We found that the unmethylated c
A
gene is transcribed at much higher levels (about 20 fold) than the
methylated copy, while both the c
G and b-globin genes are
expressed at similar levels (Figure 2). These results are consistent
with previous studies showing that DNA methylation of c gene
promoters inhibits transcription in transfected fibroblasts [22]. It
should be noted that these steady state levels of RNA in MEFs are
about 8–9 orders of magnitude less than that in fetal liver or adult
erythroblasts. Most of this inhibition is clearly independent of
DNA methylation.
In order to examine the role of DNA methylation in the control
of c-globin transcription in erythroid cells, we isolated adult
spleens from transgenic animals (lines 47, 64, 113) and separated
out erythroblasts using a cell-type specific antibody affinity
column. In these cells, the b-globin gene is expressed at very high
levels (Figure 2B). While the c-globin sequences are transcribed at
a low level compared to b-globin, this is still about 6 orders of
magnitude higher than that measured in non erythroid cells. This
increased expression is presumably due to the fact that this locus is
in a more open overall chromatin conformation in these cells. It
should be noted, however, that this amount of c
A-globin RNA is
still considerably lower than the levels produced in fetal liver.
Undermethylation of the c
A gene promoter in spleen erythroblasts
brings about a striking 20-fold average increase in the activity of
this gene as compared to its methylated counterpart in three
independent transgenic founders. In contrast, the constitutively
methylated c
G promoter remained repressed, and this serves as an
internal negative control for the induction seen with c
A.
Although the normal percentage of c globin expression in
human erythroblasts is about 5–10% of the total (c+b) (http://
www.genecards.org/index.shtml; http://symatlas.gnf.org/SymAtlas),
this ratio appears much lower (1%) in our mice, and this is, in
fact, consistent with previous data from other transgenic animals
carrying similar constructs (0.3–3%) [14,23]. In the absence of
DNA methylation on the c
A promoter, c globin expression ratio
increases (to a level of 3–6%), but if we assume that the c
G gene
is affected by demethylation to the same extent, total c/c+b
would actually be expected to reach levels of 10–25%, which is
approximately the same order of magnitude as that seen in fetal
liver (Figure 2 and or cases of transgenic HPFH (30–65%)where
both the c and b genes are active [24]. It thus appears that
DNA methylation is serving as a local mechanism to repress the
activity of c-globin genes in adult erythroid cells.
Effect of DNA methylation on histone modification
One of the mechanisms by which DNA methylation inhibits gene
expression is by bringing about the deacetylation of local histones
[3]. We therefore examined the histone modification pattern of
nucleosomes positioned in the promoter region of the c
A and c
G
genes in vivo. This was carried out by isolating mononucleosomes
from fibroblast or erythroblast cells and subjecting them to
Chromatin Immunoprecipitation (ChIP) analysis using antibodies
against Ac-H4. The active mouse b-actin and inactive a actin
genes were used as matched controls for verifying the efficacy of
immunoprecipitation.
Figure 2. Effect of DNA methylation on gene expression
A. RNA from purified adult or fetal liver erythroblasts and MEFs from Cre
(c
A promoter methylated) or Mx-cre (c
A promoter unmethylated)
crossed transgenic (lines 47, 64 or 113)) mice were subjected to semi-
quantitative RT-PCR on 1 or 3 ml samples to detect human b (HBB) or
c(HBG)-globin RNA. We measured Aprt expression to control for the
amount of cDNA in the reaction. Genes expressed at high levels were
quantitated by diluting the input sample (e.g. 1/10
5 for Aprt in MEFs). In
order to distinguish between the two c genes, we took advantage of
a PstI restriction site that is present in c
A and not c
G [51]. A smaller
induction of c
A was observed in line 66 which is only partially
unmethylated at the promoter (data not shown). The degree of IE
excision in purified erythroblasts from induced Mx-cre carrying mice
was found to be .90% by PCR analysis. The data for fetal erythroblasts
was taken from an animal with a ‘‘methylated’’ c
A gene, but we have
demonstrated that it is indeed unmethylated in fetal liver (data not
shown), as expected.
B. Quantitative analysis of RNA. Levels of globin expression were
obtained from dilution analysis and compared to Aprt (set to 1) in the
same cells. Each experiment was repeated 2–3 times (coefficient of
variance=14%). c/c+b was calculated on the basis of total c globin
(c
A+c
G). Results (average of 3 experiments) for real time PCR are
included for some samples. The degree of c globin induction is shown
for adult erythroblast cells.
doi:10.1371/journal.pone.0000046.g002
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A gene promoter in non-erythroid
cells is packaged in nucleosomes containing deacetylated histone
H4, in a manner similar to other repressed genes. Strikingly, in the
absence of DNA methylation, this region becomes acetylated,
reaching the same maximum levels probably as a result of methyl
binding proteins [12] associated with transcriptionally active genes
such as b-actin or b-globin in erythroid cells (Figure 3A). Identical
findings were observed for methylation of H3(K4) (data not
shown), which is also known to be correlated with gene activity.
This change in the histone modification pattern is surprising in
light of the fact that c-globin is expressed at such low levels in non-
erythroid cells, suggesting that as opposed to other repression
mechanisms, it is DNA methylation that plays a dominant role in
setting up or maintaining histone acetylation at this locus.
Histone acetylation was also examined in adult erythroblasts
purified from spleen. In these cells, the c genes are expressed at
levels 6 orders of magnitude greater than that seen in fibroblasts.
Despite this, both the c
G and c
A promoters are packaged with
nucleosomes containing deacetylated histone H4 (Figure 3B). This
is most likely due to the presence of DNA methylation, since
removal of these methyl moieties brings about a dramatic increase
in both the acetylation of H4 and methylation of H3(K4)
(Figure 3B and data not shown). This suggests that in erythroid
cells, it is basically DNA methylation which keeps the c genes
packaged in their deacetylated form, and this probably accounts
for their suboptimal level of expression.
Effect of DNA methylation on protein binding
One of the major effectors of globin expression in erythroid cells is
the presence of highly specific transcription factors such as
GATA1, CP1/NF-Y and NFE3 that recognize defined sequence
motifs present at many sites within the globin locus, including the
c
A promoter [25–28]. In order to test whether DNA methylation
plays a role in these interactions, we carried out in vivo footprint
analysis in both adult erythroid cells and lymphocytes derived
from the spleen. As expected, no significant footprints were
observed in the lymphoid cells (data not shown). Similarly,
footprints were also absent in normal adult erythroid cells in which
the c
A promoter is methylated. In contrast, when these methyl
groups are absent, strong footprints over both the GATA-1 and
Figure 3. Effect of DNA methylation on promoter structure
Mononucleosomes were prepared from either non-erythroid (A)o r
erythroid (B) cells taken from Cre (methylated) and Mx-cre (unmethy-
lated) founder (64) transgene crosses and subjected to ChIP analysis
using anti-Ac-H4. Input (I) and bound (B) DNA fractions were used for
semi-quantitative PCR on 1 or 3 ml samples using primer sets specific for
the c
G or loxP-inserted c
A promoter regions. For each ChIP preparation,
the Acta1 gene (green) was assayed as a negative control and the Actb
gene (yellow) as a positive control. The results are summarized in
graphic form after normalizing to Acta1 (green) enrichment (set at 1.0)
(coefficient of variance=17%). The results for the Cre (blue) and Mx-cre
(red) mice are shown. Results for b globin are presented for comparison.
The data shown for non-erythroid cells was obtained using mono-
nucleosomes from MEFs, but the graph summarizes results from 3–4
ChIP experiments on both MEFs and lymphocytes. (C)I nv i v o
footprinting of c promoter. Erythroblasts (in vivo) or purified
erythroblast DNA (in vitro) from mice carrying either a methylated or
unmethylated c
A promoter were treated with DMS. LMPCR gel. Maxam-
Gilbert lanes (AG and CT) are sequencing controls. The numbers are
according to PubMed accession number NG_000007. Putative protein
factor binding regions (rectangles) [26], DMS footprints, as in vivo
protected (open circle) or hyper-reactive (closed circle) nucleotides, are
indicated. The sizes of the circles represent relative differences in
footprint intensities. DMS footprinting on spleen lymphocytes did not
show any hyperreactive sites on unmethylated DNA, but did reveal
some slight reactivity over the distal CCAAT box on methylated DNA.
doi:10.1371/journal.pone.0000046.g003
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(Figure 3C). It should be noted that these elements themselves do
not contain any CpG sites, so it is unlikely that binding is inhibited
directly by methyl groups. Rather, it appears that these specific
protein-DNA interactions are prevented at the nucleosome level
by local methylation-mediated histone deacetylation.
DNA methylation in HPFH
In patients with Hereditary Persistence of Fetal Hemoglobin
(HPFH) the c genes are expressed at unusually high levels in adult
erythroid cells [29]. Our results on the role of DNA methylation at
this locus strongly suggest that whatever the molecular mechanism
at the source of this disease, activation of the c-globin genes should
only be possible if the promoter is demethylated. In order to test
this hypothesis, we prepared erythroblast cultures [30] from
HPFH patients with different genetic lesions, and then isolated
DNA for bisulfite analysis of the c
A and c
G genes. In normal pro-
erythroblasts, all 5 CpG sites in the c promoter region are fully
methylated. In contrast, we observed under-methylation in both
the c
A (4/7) and c
G (5/34) promoters in a patient heterozygous for
HPFH1 [31,32] (Figure 4). This skewed pattern is in keeping with
measurements showing that these patients also have a higher than
normal ratio of c
A to c
G expression [32].
Similar bisulfite results were obtained for pro-erythroblast DNA
from a patient with bu Thalassemia (IVS-II-I, GXA) [32] who
expresses high levels of c
G -globin, and in this case we detected
massive under-methylation almost exclusively at the c
G promoter
(Figure 4). These findings are consistent with earlier experiments
showing under-methylation at a single restriction site in the c
promoter regions from HPFH patients [33,34]. Taken together,
these results strongly suggest that whatever the mechanism [35,36]
involved in enhancing c gene transcription, each case of HPFH is
probably associated with molecular changes that can bring about
local demethylation or perhaps histone acetylation in adult
erythroid cells. In further support of this, we find that DNA
methylation actually affects protein binding specifically at the
exact same sites in the c promoter that are frequently involved in
HPFH [28].
DISCUSSION
In non-erythroid cells, the entire globin locus is associated with
heterochromatin [37,38] and packaged in a closed chromatin
conformation characterized by a lack of sensitivity to DNaseI [10]
and late replication timing [8]. In addition, the c promoters carry
methyl groups that were initially put on at the time of implantation
and then maintained through subsequent cell divisions. These
mechanisms apparently serve to make the locus compact and
highly inaccessible to nuclear proteins such as RNA polymerase
and its accompanying basal transcription factors (Figure 2B).
For this reason, synthesis from the c promoters initiates very
infrequently. By genetically preventing normal developmentally-
regulated DNA methylation at this site, we were able to selectively
remove a single layer of protection, thus allowing the transcription
machinery to increase initiation of RNA synthesis at the promoter
by about 20 fold. We have previously demonstrated that this is
accomplished through methyl binding proteins that locally recruit
histone deacetylase [3]. Our results strongly suggest that in the
absence of methylation, the auxiliary repression layers, which
evidently operate through very different mechanisms, are not able
to bring about local histone deacetylation.
Previous studies had shown that the human globin locus is
programmed to be turned on regionally in erythroid cells
generated at different stages of development. This is mediated
by an increase in chromatin accessibility (DNaseI sensitivity) over
the entire locus [10], as well as a shift to early replication timing
[39], an epigenetic change that also influences chromatin structure
Figure 4. c promoter methylation pattern in patients with HPFH
The c
A and c
G promoter regions were analyzed for CpG methylation on
individual clones by the bisulfite technique. To this end we used Fibach
culture erythroblasts derived from normal individuals, as well as
heterozygote HPFH1 or b
0 Thalassemia (IVS-II-I, GXA) patients. Black
circles indicate methylated CpGs, whereas open circles indicate a lack of
methylation. The numbers in the margin indicate how many clones
were fully methylated.
doi:10.1371/journal.pone.0000046.g004
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iation, the b-globin gene undergoes local demethylation [11], and
this probably represents the last stage necessary to allow the
binding of erythroid trans acting transcription factors.
Although the c-globin genes do not undergo demethylation in
adult erythroid cells and are still packaged with deacetylated
histones, chromatin changes in cis make these genes about 10
6
fold more likely to be transcribed, but this is still not sufficient to
allow the synthesis of c-globin at maximum levels. By manipulat-
ing the locus so that the c
A gene is unmethylated, however, the last
repression barrier is removed and this gene can then interact with
the strong transcription factors already present in erythroid cells,
thereby allowing near maximal levels of RNA synthesis. In-
terestingly, these factors fail to react with similar b globin
promoter elements in fetal erythroid cells [26], strongly suggesting
that this may also be due to DNA methylation. Thus, in addition
to being a basal repression mechanism in non-erythroid cells,
DNA methylation also works as a selective regulator in erythroid
cells. Since DNA methylation plays a similar role in the immune
system [41], it is possible that this represents a general fine-tuning
mechanism for controlling expression within gene clusters.
Several studies have shown that the symptoms in b-Thalassemia
can be partly alleviated by treatment with DNA demethylation
[42] or histone acetylation agents [43], presumably by bringing
about increased synthesis of c-globin. Our results provide
molecular evidence that DNA methylation is indeed the major
barrier to c expression in adult erythroid cells, and provide the
impetus to develop more specific drugs for removing methylation
from the c promoters.
MATERIALS AND METHODS
Cloning
The 120 bp IE from the hamster Aprt gene [21] was inserted as
a dimer bounded by two lox elements into an engineered PacI
restriction site 40 bp upstream to the human c
A-globin gene
transcription start site (Figure 5). The HindIII/XhaI fragment was
then cloned into the yeast integrative plasmid pRS306 that was
then inserted by homologous recombination into the human b-
globin YAC-harboring yeast cells A201F4.3 [18]. Colonies were
subsequently screened for growth on plates lacking uracil. Correct
integration was verified by Southern blot analysis. Plasmid
Figure 5. IE induces undermethylation in transgenic mice
We made transgenic embryos (12.5 dpc) using either a plasmid that contains the normal promoter of the human c
A-globin gene (-IE), or a plasmid
that contains the promoter of the human c
A-globin gene modified to harbor a dimer of the IE bounded by two lox elements (+2IE) 40 bp upstream to
the c
A transcription start site, and tested total founder embryonic DNA for methylation at specific restriction sites by southern blot analysis. This
plasmid (+2IE) was later used as a template for homologous recombination in the YAC (see methods).
The map indicates the restriction site locations according to PubMed accession number NG_00007. Bold marked restriction enzymes are methylation
sensitive. Total founder embryo DNA was digested with HindIII alone or together with CfoI, or alternatively with StuI/XbaI alone or together with
HpaII, MspI or AvaI. Southern-blot analysis was performed using probes 59 or 39 as labeled. The sizes of expected bands are indicated on the
autoradiogram. Data shown are representative of results obtained with several transgenic founder mice for each construct. From this experiment, we
conclude that a double IE is capable of inducing undermethylation over a distance of at least 500 bp in each direction.
doi:10.1371/journal.pone.0000046.g005
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growth on 5FOA and correct excision was verified by Southern
blot analysis.
Transgenic mice and methylation analysis
YAC DNA was purified from pulse-field gels according to
standard protocols [44] and injected into fertilized mouse eggs
that were transferred to foster mothers. Littermates were screened
for the b-globin YAC transgene by PCR, and positive samples
verified by Southern blot. All three transgenes (lines 47, 64, 113)
used for analysis were found to be completely intact and present as
a single copy. Founders were crossed with Cre [19] or Mx-Cre
mice [20]. To remove the IE sequences after birth Mx-Cre X
b-globin YAC F1 mice were injected 4 times with polyI-polyC
(Sigma) on alternate days. MEFs (passage number 3–4) carrying
a methylated c
A gene were prepared from Cre embryos. MEFs
carrying an unmethylated c
A gene were prepared from Mx Cre
mice and then transfected with a type 5-cytomegalovirus Cre
vector [45] to remove the IE element. Methylation patterns in
non erythroid cells were analyzed either by Southern blot or
bisulfite methylation analysis as described [46]. Following treat-
ment, the DNA was amplified using the PCR primers forward -1
(59-TTGTTTGAAAGGGTTTTTGGTTAAATTTTATTT-39)
and reverse-1 (59-TCCTAATCACCAAAACCTACCTTCCCA-
AAA-39) and subsequently with the nested primers forward -2
(59-TTTTGGTTAAATTTTATTTATGGGTTGGTTAGTT-39)
and reverse-2 (59-AACTTATAATAATAACCTTATCCTCCT-
CTATAAAATA-39). The resulting products were cloned using
the pGEM-T Easy Vector System I kit (Promega) and indivi-
dual colonies then sequenced. Methylation patterns in purified
erythroid cells were analyzed by digestion with methylation
sensitive restriction enzyme followed by amplification by PCR.
Semiquantitative RT-PCR
Erythroblasts from fetal liver and adult spleen of Cre or Mx-cre
crossed transgenic mice were isolated by MACS (Magnetic
Activated Cell Sorter) with biotinilated a-ter119 antibodies
(PharMingen). Mouse embryonic fibroblasts (MEFs) were derived
from Cre or Mx-cre crossed 12.5 dpc transgenic embryos. RNA
was extracted with TriPure Isolation reagent (Roche), treated
(250 ng) with DNaseI (Promega) and converted to cDNA using the
Molony murine leukemia virus reverse transcriptase (Promega)
and random hexanucleotide pd(N)6 primers (Pharmacia) in
a reaction volume of 50 ml under conditions recommended by
the manufacturer. 1 or 3 ml of the cDNA was used for PCR
reactions (95uC for 1 min, 58uC for 1 min, 72uC for 1 min) in the
presence of
32PadCTP (Amersham) using appropriate primer pairs
[47]. These primers were designed to span intron-exon junctions
in order to distinguish between cDNA and genomic DNA. RT-
PCR fragments were separated on 5% or 7% polyacrylamide gels
and exposed for autoradiography. The relative amount of c
A and
c
G cDNA was defined by digestion with the restriction enzyme PstI
that cuts only the c
A PCR product. The level of c and b-globin
transcription was measured by phosphor-imager analysis of diluted
samples after normalizing for Aprt.
Chromatin Immunoprecipitation (ChIP)
Nuclei were prepared from cell culture or purified mouse spleen
erythroblasts, treated with an HDAC inhibitor (PMSF) and
digested by MNase (micrococcal nuclease) to generate mono-
nucleosomes that were separated on a sucrose gradient [48].
Immunoprecipitation (IP) was carried out using anti-acetylated
histone H4 or anti me-H3(Lys4) antibodies (Upstate Biotechnol-
ogies), and the bound fraction purified by protein A-Sepharose
chromatography (Sigma). Input and Bound DNA fractions were
analyzed by semiquantitative PCR using two concentrations.
Primer sequences are available upon request.
In vivo footprinting
In vivo Dimethyl Sulfate (DMS) footprinting and ligation-
mediated PCR (LMPCR) was performed as described earlier
[49,50], except that the in vivo DMS treatment was done on
erythroid cells in cell suspension. In a 50 ml conical tube, 10–25
million cells were suspended in 10 ml of culture medium without
bovine serum. DMS was added to a final concentration of 0.2%,
and the cells were incubated at room temperature for 5 min.
40 ml of ice-cold PBS was added to stop the DMS reaction and
the cells were centrifuged quickly (250 g, 3 min), washed two times
with 30 ml of ice-cold PBS before DNA preparation. For the
LMPCR experiment we designed the first primers in such way
that they distinguished between the c
G and lox-P inserted c
A
promoters. Primer extension was then carried out with either L1n:
59-GCGTCTGGACTAGGAGCTTTTAAT-39 or L1: 59-AAG-
TAACGCATTTGCT GGAAG-39 (which includes the IE
element). Primer, L2: 59-TTAATCTCAGACGTTCCAGAAGC-
GAGTGTG-39 and LP25 linker primer were used for amplifica-
tion. The run off hybridization probe was made on PCR fragment
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